Navigation Links
Researchers find roadmap to next-generation cancer therapies
Date:5/25/2008

Pinpointing new targets for cancer treatments is as difficult as finding a needle in a haystack, yet a University of Rochester team has discovered an entire novel class of genes they believe will lead to a greater understanding of cancer cell function and the next generation of effective and less harmful therapies for patients.

In a paper in the journal Nature, available online May 25, the researchers describe how multiple cancer genes cooperate to cause malignant cell transformation. Further, they describe the discovery of approximately 100 genes that work downstream of known cancer-causing mutations, providing a host of new opportunities for intervention.

We believe that we have found a cornerstone for development of new treatments that ultimately will allow selection of drugs and drug combinations from a pool of compounds directed against these new genes, said lead author Hartmut Land, Ph.D., professor and chair of the Department of Biomedical Genetics at the University of Rochester Medical Center and scientific director of the James P. Wilmot Cancer Center at the URMC.

However, much more work needs to be done to explore how our findings may lead to successful targeting of various cancer types and cancer stem cells, he said.

Targeted cancer therapy such as the drug Gleevec that works for patients with certain types of leukemia and gastrointestinal tumors is based on a keen understanding of the architecture of cancer. Much has been learned in the past several years, but what has been lacking is a clear roadmap leading to dozens of new molecular targets.

Twenty-five years ago Land was among the first scientists to discover that malignant cell transformation required multiple mutations in distinct cancer genes. Ever since, he has been studying the cooperative nature of this process and the inner workings of cancer cell function.

His research group began testing, at the genomic scale, a prediction that gen
'/>"/>

Contact: Leslie Orr
Leslie_Orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Monitoring blood flow helps improve prostate biopsies, Jefferson researchers report
2. 2008 LOreal USA Fellowships For Women in Science Awarded to Five Groundbreaking Researchers
3. Researchers explore the emerging role of infection in Alzheimers disease
4. 2 LA BioMed researchers named Heroes of Emergency Medicine
5. Virtual biopsy can tell whether colon polyp is benign without removal, Mayo researchers say
6. Researchers close in on new melanoma gene
7. Traditional herbal medicine kills pancreatic cancer cells, Jefferson researchers report
8. Researchers develop first transgenic monkey model of Huntingtons disease
9. Researchers expand natural killer cells in cord blood to fight leukemia
10. Medical College of Wisconsin researchers identify proteins that help develop mammalian hearts
11. Mastectomies on the rise and MRI use may explain part of the trend, say Mayo researchers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...wswire/ -- Chiltern International Limited (Chilter...providing clinical development and staffing servic...es the appointment of Dr. Sharon Moore as Execut...ffairs. Dr. Moore is based at Chiltern,s Bristol, ...ian with 15 years of industry experience. Prior to...
(Date:12/3/2009)...ec. 3 For California,s 3.4 million...lity remains one of the most significant threats t...t also their business,s viability. ,, "As the ...l, owners of small businesses are recognizing the ...nhanced disability coverage," said Michael Hagedo...
(Date:12/3/2009)...to an understanding of how accurate DNA replicatio...ancer and genetic diseases ,, DETROIT, Dec. 3 ... have for the first time observed the movement of ...ates nucleotides one by one. More significantly, t... they speculate is part of the proofreading proces...
(Date:12/3/2009)...ocedures on young women caused by outdated HPV tes...on December 11 for blocking new technology. , ... 2, 2009 -- Now the American College of Obstetric...sive cancer workup procedure, also known as colpo...o some women who have received the procedure . How...
(Date:12/3/2009)...ewswire/ -- According to the World Health Organiza...lu") has reached a pandemic level. Over 500,000 c...,500 fatalities. Since there is no longer a requi...numbers undoubtedly understate the real situation....prnh/20091203/NY20654 ) ,, There are currently...
Breaking Medicine News(10 mins):Health News:Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4Health News:Wayne State Researchers Report a Possible 'Proofreading' Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase 2Health News:Wayne State Researchers Report a Possible 'Proofreading' Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase 3Health News:Harmful Procedures on Young Women Caused by Outdated HPV test, not by Pap Test 2Health News:Buchang Global Health Forum 2009: An Innovative Approach for Management of H1N1 Swine Flu 2
...onetics Europe, BRAINTREE, Mass., Nov. 8 Haemone...l Gordon will join the company,effective November ...ordon,will have responsibility for European operat...and. He will also join,Haemonetics, global Operati...
...-FirstCall/ -- China Sky One,Medical, Inc. (OTC Bu...distributor of pharmaceutical, medicinal and diagn...s completed the previously announced amendment to,...ded September 30, 2007, management determined that...
...VES, RANCHO CORDOVA, Calif., Nov. 8 ThermoGenesi...novative products and,services that process, store...ells for treatment of disease and injury, today re...4.3 million for the first quarter of fiscal,2007. ...
...stribution Channels, OWINGS MILLS, Md., Nov. 8 M...quarter results for the period ended,September 30,...ast reported,revenue of $21.8 million, an 11% incr... versus $1,455,000 or $0.11 per basic,share ($0.11...
...troke and heart attacks, revised label warns , ...S. Food and Drug Administration on Thursday approv...iesis-stimulating agents, which are drugs used to ...ts with chronic kidney failure. Those dangers incl...
... ),announced today that it will present at the Cre...uesday, November 13, 2007 at 11:00 a.m. Eastern,Ti... Senior Vice President,Wyeth and President, Wyeth ... the conference. Wyeth is one of the world,s larg...
Other Medicine News:Health News:Haemonetics Appoints Executive Leadership of European Operations 2Health News:China Sky One Medical Completes Previously Announced Amendment to 2006 Form 10KSB 2Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 2Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 3Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 4Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 5Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 6Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 7Health News:Medifast Announces Third-Quarter 2007 Results 2Health News:Medifast Announces Third-Quarter 2007 Results 3Health News:Medifast Announces Third-Quarter 2007 Results 4Health News:Medifast Announces Third-Quarter 2007 Results 5Health News:Medifast Announces Third-Quarter 2007 Results 6Health News:Medifast Announces Third-Quarter 2007 Results 7Health News:Medifast Announces Third-Quarter 2007 Results 8Health News:FDA Issues New Warnings for Anemia Drugs 2Health News:FDA Issues New Warnings for Anemia Drugs 3
(Date:12/3/2009)...Dec. 3 Radiology imaging leader ME...egration capabilities at the November 2009 Radiolo...ect.PACS(TM) product, enabling the first radiolog...est release in the company,s newly branded Certeg...tp://www.newscom.com/cgi-bin/prnh/20091203/NE20631...
(Date:12/3/2009)... ParagonRx, a Delaware-based compa...and optimal medication use, will host a free webin...ce on REMS - Risk Evaluation Mitigation Strategy -...management. Dr. Gary Slatko, chief medical office...gement programs, will lead the one-hour program be...
(Date:12/3/2009)...mark and SAN DIEGO, California, December 3 /PRNews...s miR-122, a microRNA Important for,Hepatitis C Vi...patitis C,Virus in the Bloodstream in Chimpanzees ..., - SPC3649 Demonstrates Efficacy With No E... Events in the Treated Animals - Signaling a Poten...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Paraplegic Takes Leap of Faith for Treatment in India 50232 1Paraplegic Takes Leap of Faith for Treatment in India 50232 2Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 1Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 2Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 3Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 4Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 5Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 6Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 7Ozone depletes oil seed rape productivity 9037 1
Premier Thumb Spica
FREEDOM® Memory Thumb Spica
QualCraft™ Gamekeeper Thumb Stabilizer
...dom® CMC ThumbFit™ reduces joint instabi...ofile splint is remarkably comfortable and easy fo... CHT and Robert V. Sypher Jr., MD, FAAOS, develope...plaints of discomfort and impaired hand function f...
Medicine Products: